Active ingredient:
ambroxol hydrochloride.
IndicationsMucolytic therapy of productive cough in acute or chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
ContraindicationsHypersensitivity to the active substance or to any of the excipients.
Do not use in children under 6 years of age.
Pregnancy and breastfeedingAmbroxol hydrochloride crosses the placental barrier.
Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development.
Extensive clinical experience after the 28th week of pregnancy has shown no evidence of harmful effects on the foetus.
Nonetheless, the usual precautions regarding the use of drugs during pregnancy should be observed.
Especially during the first trimester, the use is not recommended.
Ambroxol hydrochloride is excreted in breast milk.
Although unfavourable effects on breastfeed infants would not be expected, is not recommended for use in nursing mothers.
This is an OTC medicine, so it can be taken without a doctor's recommendation.
Before using this medicine carefully read the package leaflet as it contains more detailed information.
Consult your doctor or pharmacist for any doubt.

Adults and children above 12 years old:
5 ml oral solution (30 mg ambroxol hydrochloride) administered 3 times daily (equivalent to 90 mg ambroxol hydrochloride per day) during the first 2 to 3 days.
After that, 5 ml oral solution is administered twice daily (equivalent to 60 mg ambroxol hydrochloride per day).
For adults, the dose may be increased up to 60 mg ambroxol hydrochloride, twice daily (equivalent to 120 mg ambroxol hydrochloride per day) if needed.

Ambroxol hydrochlorideSodium benzoate (E211)Sorbitol (Е420)SucraloseHydroxyethylcelluloseCitric acid monohydratePurified waterStrawberry flavour (501440 T):
Propylene glycol (E1520)Flavouring substances